Wren Therapeutics Ltd Revenue and Competitors
Estimated Revenue & Valuation
- Wren Therapeutics Ltd's estimated annual revenue is currently $4M per year.
- Wren Therapeutics Ltd's estimated revenue per employee is $77,500
- Wren Therapeutics Ltd's total funding is $40.3M.
Employee Data
- Wren Therapeutics Ltd has 52 Employees.
- Wren Therapeutics Ltd grew their employee count by -22% last year.
Wren Therapeutics Ltd's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, President | Reveal Email/Phone |
2 | VP Innovation | Reveal Email/Phone |
3 | VP Early Discovery | Reveal Email/Phone |
4 | Head Data and Analytics | Reveal Email/Phone |
5 | Head Wren Sweden | Reveal Email/Phone |
6 | Head Kinetics | Reveal Email/Phone |
7 | Head Translational Science & Pre-Clinical Development | Reveal Email/Phone |
8 | VP Neurobiology | Reveal Email/Phone |
9 | Finance Director | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Wren Therapeutics Ltd Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Wren Therapeutics Ltd?
Wren (www.wrentherapeutics.com) is a spin-off company from the University of Cambridge (UK) and Lund University (Sweden), focused on drug discovery and development for protein misfolding diseases. Wren is advancing an entirely novel approach to address this class of diseases, based on more than a decade of research from its scientific founders focused on the chemical kinetics of the protein misfolding process. These advances make it possible to map, and selectively modulate, the complex and non-linear chemical kinetic networks associated with misfolding proteins and disease. Wren's predictive, quantitative platform is built on concepts from the physical sciences and is a fundamental shift from the descriptive, qualitative methods of traditional biology, which have failed to successfully address these complex systems. Wren is using its unique approach to develop a broad pipeline of small molecule and antibody therapeutics, as well as diagnostics, spanning neurology, ophthalmology and metabolic diseases.
keywords:N/A
$40.3M
Total Funding
52
Number of Employees
$4M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Wren Therapeutics Ltd News
Mitorx Therapeutics Ltd. is poised to develop small molecules that reverse ... Wren Capital, Longevitytech.fund, the Fink family office,...
Wren Therapeutics announces financing of £12.4 million 25-01-2021 Wren Therapeutics Ltd, a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17 million) financing. Wren ...
Wren Therapeutics announces financing of £12.4 million 25-01-2021 Wren Therapeutics Ltd, a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17 million) financing. Wren ...
Wren Therapeutics announces financing of £12.4 million 25-01-2021 Wren Therapeutics Ltd, a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17 million) financing. Wren ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 52 | -4% | N/A |
#2 | $6.6M | 52 | N/A | N/A |
#3 | $12.6M | 52 | -46% | N/A |
#4 | $8.1M | 52 | -4% | N/A |
#5 | $6.8M | 52 | 8% | N/A |